|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/30/21 Orthofix Medical Inc. 10-Q 3/31/21 75:7.3M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 675K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 29K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 29K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 25K
11: R1 Document and Entity Information HTML 75K
12: R2 Condensed Consolidated Balance Sheets HTML 104K
13: R3 Condensed Consolidated Balance Sheets HTML 33K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Income and HTML 108K
Comprehensive Income (Loss)
15: R5 Condensed Consolidated Statements of Changes in HTML 57K
Shareholders' Equity
16: R6 Condensed Consolidated Statements of Cash Flows HTML 112K
17: R7 Business, basis of presentation, COVID-19 update, HTML 33K
and CARES Act
18: R8 Recently adopted accounting standards and recently HTML 33K
issued accounting pronouncements
19: R9 Acquisitions HTML 42K
20: R10 Inventories HTML 45K
21: R11 Leases HTML 103K
22: R12 Long-term debt HTML 25K
23: R13 Fair value measurements and investments HTML 189K
24: R14 Contingencies HTML 28K
25: R15 Accumulated other comprehensive loss HTML 50K
26: R16 Revenue recognition and accounts receivable HTML 108K
27: R17 Business segment information HTML 110K
28: R18 Acquisition-Related Amortization and Remeasurement HTML 44K
29: R19 Share-based compensation HTML 68K
30: R20 Income taxes HTML 28K
31: R21 Earnings per share ("Eps") HTML 48K
32: R22 Subsequent Events HTML 25K
33: R23 Recently adopted accounting standards and recently HTML 25K
issued accounting pronouncements (Policies)
34: R24 Acquisitions (Tables) HTML 40K
35: R25 Inventories (Tables) HTML 45K
36: R26 Leases (Tables) HTML 104K
37: R27 Fair value measurements and investments (Tables) HTML 191K
38: R28 Accumulated other comprehensive loss (Tables) HTML 49K
39: R29 Revenue recognition and accounts receivable HTML 104K
(Tables)
40: R30 Business segment information (Tables) HTML 107K
41: R31 Acquisition-Related Amortization and Remeasurement HTML 43K
(Tables)
42: R32 Share-based compensation (Tables) HTML 69K
43: R33 Earnings per share ("Eps") (Tables) HTML 46K
44: R34 Business, basis of presentation, COVID-19 update, HTML 32K
and CARES Act - Additional information (Detail)
45: R35 Recently Adopted Accounting Standards and Recently HTML 37K
Issued Accounting Pronouncements - Additional
Information (Detail)
46: R36 Acquisitions - Additional Information (Detail) HTML 35K
47: R37 Acquisitions - Summary of Fair Values of Assets HTML 38K
Acquired and Liabilities Assumed (Detail)
48: R38 Inventories - Schedule of Inventories (Detail) HTML 34K
49: R39 Leases - Summary of Lease Portfolio (Detail) HTML 50K
50: R40 Leases - Summary of Supplemental Cash Flow HTML 36K
Information Related to Leases (Detail)
51: R41 Long-Term Debt - Additional Information (Detail) HTML 29K
52: R42 Fair Value Measurements and Investments - Schedule HTML 53K
of Financial Assets and Liabilities Measured at
Fair Value on Recurring Basis (Detail)
53: R43 Fair Value Measurements and Investments - HTML 61K
Additional Information (Detail)
54: R44 Fair Value Measurements and Investments - Schedule HTML 39K
of Reconciliation For Contingent Consideration
Measured At Fair Value Using Significant
Unobservable Inputs (Level 3) (Detail)
55: R45 Fair Value Measurements and Investments - Schedule HTML 59K
of Valuation Methodology and Unobservable Inputs
for Level 3 Assets and Liabilities Measured at
Fair Value (Detail)
56: R46 Contingencies - Additional Information (Detail) HTML 30K
57: R47 Accumulated Other Comprehensive Loss - Components HTML 39K
of Changes in Accumulated Other Comprehensive Loss
(Detail)
58: R48 Revenue Recognition and Accounts Receivable - HTML 42K
Schedule of Net Sales by Major Product Category by
Reporting Segment (Detail)
59: R49 Revenue Recognition and Accounts Receivable - HTML 31K
Schedule of Components of Net Sales (Detail)
60: R50 Revenue Recognition and Accounts Receivable - HTML 33K
Schedule of Allowance for Expected Credit Losses
(Detail)
61: R51 Revenue Recognition and Accounts Receivable - HTML 49K
Additional Information (Detail)
62: R52 Business Segment Information - Additional HTML 24K
Information (Detail)
63: R53 Business Segment Information - Summary of EBIDTA HTML 41K
by Reporting Segment (Detail)
64: R54 Business Segment Information - Summary of Net HTML 41K
Sales by Geographic Destination for Each Reporting
Segment (Detail)
65: R55 Acquisition-Related Amortization and Remeasurement HTML 31K
- Components of Acquisition-Related Amortization
and Remeasurement (Detail)
66: R56 Share-based Compensation - Schedule of Components HTML 44K
of Share-Based Compensation Expense (Detail)
67: R57 Share-based Compensation - Additional Information HTML 24K
(Detail)
68: R58 Income Taxes - Additional Information (Detail) HTML 34K
69: R59 Earnings Per Share ("EPS") - Schedule of HTML 36K
Reconciliation of Weighted Average Shares Used in
Diluted EPS (Detail)
70: R60 Earnings Per Share ("EPS") - Additional HTML 28K
Information (Detail)
71: R61 Subsequent Events - Additional Information HTML 30K
(Detail)
73: XML IDEA XML File -- Filing Summary XML 140K
10: XML XBRL Instance -- ofix-10q_20210331_htm XML 1.77M
72: EXCEL IDEA Workbook of Financial Reports XLSX 74K
6: EX-101.CAL XBRL Calculations -- ofix-20210331_cal XML 154K
7: EX-101.DEF XBRL Definitions -- ofix-20210331_def XML 416K
8: EX-101.LAB XBRL Labels -- ofix-20210331_lab XML 1.01M
9: EX-101.PRE XBRL Presentations -- ofix-20210331_pre XML 764K
5: EX-101.SCH XBRL Schema -- ofix-20210331 XSD 172K
74: JSON XBRL Instance as JSON Data -- MetaLinks 332± 504K
75: ZIP XBRL Zipped Folder -- 0001564590-21-022230-xbrl Zip 150K
 | Download this zipped .zip folder |
| Files: | gg5q1rd5ylim000001.jpg ofix-10q_20210331.htm ofix-20210331.xsd ofix-20210331_cal.xml ofix-20210331_def.xml ofix-20210331_lab.xml ofix-20210331_pre.xml ofix-ex311_6.htm ofix-ex312_7.htm ofix-ex321_9.htm |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/06/21 Orthofix Medical Inc. S-8 8/06/21 3:190K ActiveDisclosure/FA 8/06/21 Orthofix Medical Inc. S-8 8/06/21 3:187K ActiveDisclosure/FA |